Marshall Wace’s Innovid Corp. CTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-397,940
Closed -$1.23M 3197
2024
Q4
$1.23M Buy
+397,940
New +$939K ﹤0.01% 1638
2024
Q3
Sell
-140,465
Closed -$260K 3053
2024
Q2
$260K Sell
140,465
-155,050
-52% -$332K ﹤0.01% 2212
2024
Q1
$736K Buy
295,515
+187,620
+174% +$325K ﹤0.01% 1777
2023
Q4
$162K Sell
107,895
-310,233
-74% -$395K ﹤0.01% 2006
2023
Q3
$535K Sell
418,128
-179,469
-30% -$210K ﹤0.01% 1701
2023
Q2
$651K Buy
+597,597
New +$620K ﹤0.01% 1890
2021
Q4
Sell
-120,514
Closed -$1.19M 4362
2021
Q3
$1.19M Buy
120,514
+20,554
+21% +$203K 0.01% 1916
2021
Q2
$989K Buy
+99,960
New +$998K ﹤0.01% 1813

Marshall Wace's CTV Position: Q1 2025 in Review

Marshall Wace sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 397,940 shares — an estimated $1.23M sold.

Marshall Wace first reported a position in CTV in Q2 2021 and held it in 8 quarters. The position peaked at $1.23M in Q4 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

  • Marshall Wace reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
  • Marshall Wace sold 397,940 Innovid Corp. shares in Q1 2025, an estimated $1.23M.
  • Marshall Wace first reported a position in Innovid Corp. in Q2 2021 and held it in 8 quarters.
  • Marshall Wace's Innovid Corp. position peaked at $1.23M in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.